Drug Pricing & Regulations: Changes in government drug pricing policies significantly impact revenue.

Raw Material Costs: Fluctuations in the price of active pharmaceutical ingredients (APIs) and other raw materials affect profitability.

Competition: The entry of new players or increased competition in existing markets can erode market share and pricing power.

Regulatory Approvals: Delays or rejections in regulatory approvals for new products can negatively affect future growth prospects.

Global Market Conditions: Economic conditions and healthcare spending patterns in key export markets influence demand.

Currency Exchange Rates: Fluctuations in exchange rates, particularly the USD/INR rate, impact export revenues and profitability.

Company-Specific News: Announcements regarding earnings, new product launches, mergers, and acquisitions directly affect investor sentiment.

Overall Market Sentiment: General market trends and investor risk appetite influence stock valuations.

Research & Development: Success in developing and launching new drugs can drive long-term growth and stock price appreciation.

Manufacturing Issues: Production disruptions or quality control issues can lead to product recalls and decreased sales.